Advertisement

Scientists led by Dr Katrina Williams, of the Children's Hospital at Westmeade, concluded that intravenous doses of secretin - considered by some to be a promising treatment for autism - did not improve autism-related social, behavioural or communication problems.

The findings appear in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international group dedicated to evaluating contemporary medical research.

Should not be administered as a treatment for autism
Secretin," should not currently be recommended or administered as a treatment for autism," the review authors wrote.

They did not find any serious side effects reported in the studies, but said that, "more adverse events are likely to be reported if secretin is made widely available."

In 1998, a series of small studies at the University of Maryland suggested that secretin might be useful in treating autism.

"Since then, the use of secretin has become widespread, and it is currently being dispensed in many different forms and in countries where it is not licensed," Williams said in a prepared statement. – (HealthDayNews)

Visit our Autism Centre for more information.
 

Print this article on

Rate this article Poor 1 2 3 4 5 Excellent

JOBS

DELPHI DEVELOPER Gauteng - Johannesburg C++ DEVELOPERS Gauteng SENIOR C++ DEVELOPERS Gauteng - Johannesburg SENIOR .NET DEVELOPERS Gauteng SNR C# / .NET DEVELOPER Gauteng WEB DEVELOPERS Gauteng JAVA / J2EE DEVELOPERS Gauteng C# DEVELOPERS Gauteng - Pretoria Find more jobs Register your CV Post a job